PRGO
Perrigo Co. Plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IE
$13.56
+0.59%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $0.52
- Revenue estimate
- $991.5M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- $0.50
- EPS estimate
- $0.39
- Revenue actual
- $1.0B
- Revenue estimate
- $1.0B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +10.5%
- Revenue beats (12Q)
- 2
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $0.39 | $0.50 | Beat 28.87% | $1.0B |
| May 6, 2026 | $0.39 | $0.43 | Beat 10.26% | $969.2M |
| Feb 26, 2026 | $0.80 | $0.77 | Miss -3.75% | $1.1B |
| Nov 5, 2025 | $0.75 | $0.80 | Beat 6.67% | $1.0B |
| Aug 6, 2025 | $0.59 | $0.57 | Miss -3.39% | $1.1B |
| Feb 27, 2025 | $0.92 | $0.93 | Beat 1.09% | $1.1B |
| Aug 2, 2024 | $0.48 | $0.53 | Beat 10.42% | $1.1B |
| Feb 27, 2024 | $0.83 | $0.86 | Beat 3.61% | $1.2B |
| Feb 27, 2023 | $0.70 | $0.75 | Beat 7.14% | $1.2B |
| Mar 1, 2022 | $0.56 | $0.60 | Beat 7.14% | $1.1B |
| Nov 10, 2021 | $0.65 | $0.45 | Miss -30.77% | $1.0B |
| Aug 11, 2021 | $0.61 | $0.50 | Miss -18.03% | $981.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026